Search results
Results from the WOW.Com Content Network
The Baupost Group is a hedge fund [3] founded in 1982 by William Poorvu and partners Howard Stevenson, Jordan Baruch and Isaac Auerbach. Seth Klarman, who was asked by Poorvu to help run the fund, remains at its head today. [4] Baupost Group's investment philosophy emphasizes risk management and is long-only.
Seth Andrew Klarman (born May 21, 1957) [1] [2] is an American billionaire investor, hedge fund manager, and author. He is a proponent of value investing.He is the chief executive and portfolio manager of the Baupost Group, a Boston-based private investment partnership he founded in 1982.
For premium support please call: 800-290-4726 more ways to reach us
Poorvu is the co-founder, chairman, and co-chair of the advisory board of the hedge fund The Baupost Group, [4] currently led by Seth Klarman with $29.4 billion AUM in 2012. . He is a member of the Carnegie Corporation Investment Committee and a former member of the Yale University Investment Committee and of the Yale University Counc
Firm's largest sales of the 2nd quarter. For premium support please call: 800-290-4726 more ways to reach us
Keryx Biopharmaceuticals Inc. (NASDAQ: KERX) has not been a household name in biotech investing, but the move on news on Monday has put the company on the map. After shares are up almost 95% at $6 ...
In February 2012, together with Seth Klarman of the Baupost Group, Horovitz launched The Times of Israel, an English-language Israeli news website published out of Jerusalem. [3] Horovitz has also written about Israel for newspapers around the world, including The New York Times, Los Angeles Times, The Irish Times and The Independent in London.
Let's take a look at Keryx Biopharmaceuticals (NAS: KERX) today, Examine its pros and cons, and decide whether its possible upsides outweigh its risks. Buy, Sell, or Hold: Keryx Pharmaceuticals